Federal Court Approves Venue Change in Ventis Pharma’s False Advertising Lawsuit to California

Ventis Pharma Inc., a company specializing in the development of nonopioid anesthetics, has received a federal court’s approval to relocate a false advertising lawsuit filed by its competitor, Pacira BioSciences Inc., from Delaware to California. This decision, rendered on Friday, moves the case to Ventis’s home state, potentially giving them strategic advantages in dealing with the legal matter on their home turf. The original announcement can be found on Law360’s website.